| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 002 | 3 | NIH | 3/29/2024 | $0 |
| | 2024 | 2023 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 001 | 3 | NIH | 3/21/2024 | $0 |
| | 2024 | 2023 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 000 | 3 | NIH | 12/14/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $712,471 ) |
| | 2023 | 2023 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 001 | 3 | NIH | 6/29/2023 | $712,471 |
| | 2023 | 2022 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 000 | 2 | NIH | 3/22/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $734,433 ) |
| | 2022 | 2022 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R44DC017625 | Automated objective outcome measures for clinical use in dysarthria | 000 | 2 | NIH | 6/8/2022 | $734,433 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | AURAL ANALYTICS, INC. | 1355 N SCOTTSDALE RD STE 110 | SCOTTSDALE | AZ | 85257-3550 | MARICOPA | USA | R43DC017625 | Automated objective outcome measures for clinical use in dysarthria | 000 | 1 | NIH | 6/25/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $224,910 ) |
| | 2019 | 2019 | AURAL ANALYTICS, INC. | 1475 N SCOTTSDALE RD STE 200 | SCOTTSDALE | AZ | 85257-3538 | MARICOPA | USA | R43DC017625 | Automated objective outcome measures for clinical use in dysarthria | 000 | 1 | NIH | 1/7/2019 | $224,910 |
|
|
